Analystreport

Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) had its "buy" rating re-affirmed by analysts at HC Wainwright.

Satsuma Pharmaceuticals, Inc. - Common stock  (STSA) 
Last satsuma pharmaceuticals, inc. - common stock earnings: 3/10 04:01 pm Check Earnings Report